Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 19 studies | 49% ± 13% | |
lung | 17 studies | 38% ± 13% | |
intestine | 11 studies | 35% ± 15% | |
brain | 10 studies | 29% ± 10% | |
kidney | 8 studies | 36% ± 9% | |
eye | 8 studies | 29% ± 10% | |
liver | 7 studies | 35% ± 16% | |
lymph node | 6 studies | 46% ± 14% | |
uterus | 5 studies | 44% ± 20% | |
pancreas | 4 studies | 58% ± 21% | |
placenta | 4 studies | 34% ± 11% | |
bone marrow | 4 studies | 47% ± 20% | |
breast | 4 studies | 44% ± 6% | |
prostate | 3 studies | 30% ± 7% | |
adipose | 3 studies | 27% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 24211.24 | 459 / 459 | 100% | 208.55 | 1118 / 1118 |
intestine | 100% | 19796.17 | 966 / 966 | 100% | 182.81 | 527 / 527 |
ovary | 100% | 42716.91 | 180 / 180 | 100% | 162.42 | 430 / 430 |
pancreas | 100% | 20144.20 | 328 / 328 | 100% | 152.04 | 178 / 178 |
prostate | 100% | 16898.75 | 245 / 245 | 100% | 247.51 | 502 / 502 |
esophagus | 100% | 17116.57 | 1444 / 1445 | 100% | 138.33 | 183 / 183 |
skin | 100% | 26270.12 | 1809 / 1809 | 100% | 215.19 | 471 / 472 |
thymus | 100% | 18750.62 | 653 / 653 | 100% | 238.92 | 603 / 605 |
lung | 100% | 15842.44 | 576 / 578 | 100% | 155.09 | 1155 / 1155 |
stomach | 100% | 17184.62 | 359 / 359 | 100% | 158.43 | 285 / 286 |
kidney | 100% | 15227.26 | 89 / 89 | 99% | 214.41 | 894 / 901 |
bladder | 100% | 20680.57 | 21 / 21 | 99% | 138.64 | 500 / 504 |
uterus | 100% | 26166.68 | 170 / 170 | 99% | 138.11 | 454 / 459 |
adrenal gland | 100% | 19661.58 | 258 / 258 | 98% | 137.48 | 226 / 230 |
brain | 98% | 9514.35 | 2588 / 2642 | 100% | 153.51 | 705 / 705 |
liver | 96% | 6636.72 | 218 / 226 | 98% | 109.06 | 397 / 406 |
adipose | 100% | 23195.45 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 19373.18 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 370.52 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 228.43 | 29 / 29 |
muscle | 100% | 31301.28 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 15805.92 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 142.55 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 56.90 | 1 / 1 |
peripheral blood | 95% | 16358.71 | 879 / 929 | 0% | 0 | 0 / 0 |
heart | 92% | 10527.70 | 792 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006446 | Biological process | regulation of translational initiation |
GO_0006413 | Biological process | translational initiation |
GO_0005829 | Cellular component | cytosol |
GO_0016281 | Cellular component | eukaryotic translation initiation factor 4F complex |
GO_0003743 | Molecular function | translation initiation factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | EIF4B |
Protein name | Eukaryotic translation initiation factor 4B (eIF-4B) Alternative protein EIF4B eIF4B protein Eukaryotic translation initiation factor 4B |
Synonyms | |
Description | FUNCTION: Required for the binding of mRNA to ribosomes. Functions in close association with EIF4-F and EIF4-A. Binds near the 5'-terminal cap of mRNA in presence of EIF-4F and ATP. Promotes the ATPase activity and the ATP-dependent RNA unwinding activity of both EIF4-A and EIF4-F. |
Accessions | F8VRU1 ENST00000552490.5 ENST00000420463.7 ENST00000549481.5 ENST00000416762.7 [P23588-2] ENST00000549077.5 F8VYE9 F8VX11 E7EX17 ENST00000262056.14 [P23588-1] P23588 F8VSC7 F8W0K0 Q7Z5Y0 ENST00000551002.5 L8EC87 ENST00000550704.5 F8VP89 ENST00000550390.1 |